GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported a loss of $202.4 million in its third quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $1.25. Losses, adjusted for asset impairment costs and to extinguish debt, came to 62 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.08 per share.
The vaccine maker posted revenue of $70.4 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $39.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVAX at https://www.zacks.com/ap/NVAX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
